Plasma factor in schizophrenia
Frohman, C.E.
Biological Psychiatry 11(2): 251-252
1976
ISSN/ISBN: 0006-3223 PMID: 61046 Document Number: 107049
Document emailed within 1 workday
Related Documents
Martinotti, G.; Di Iorio, G.; Marini, S.; Ricci, V.; De Berardis, D.; Di Giannantonio, M. 2012: Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review Journal of Biological Regulators and Homeostatic Agents 26(3): 347-356Baron, M.; Levitt, M.; Asnis, L.; Fein, M. 1983: Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity Biological Psychiatry 18(5): 579-582
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
James O' Donnell and Michael Laffan 2001: Elevated Plasma Factor VIII Levels - a Novel Risk Factor for Venous Thromboembolism Clinical Laboratory 47(1-2): 1-6
España, F.; Ratnoff, O.D. 1983: Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases Journal of Laboratory and Clinical Medicine 102(1): 31-45
Takamiya, O.; Funahashi, S.; Yoshioka, K. 1986: Preparation of factor VII-depleted plasma by immunoaffinity chromatography of insolubilized anti-factor VIi Medical Laboratory Sciences 43(3): 215-219
Brinkhous, K.M.; Thomas, B.D.; Ibrahim, S.A.; Read, M.S. 1977: Plasma levels of platelet aggregating factor/vom Willebrand factor in various species Thrombosis Research 11(3): 345-355
Nieuwenhuys, C.M.; Feijge, M.A.; Béguin, S.; Heemskerk, J.W. 2000: Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma Thrombosis and Haemostasis 84(6): 1045-1051
Baishev, I.M.; Zubairov, D.M. 1986: Effect of a factor XIi inhibitor isolated from kernels of corn on the cold activation of factor VIi in blood plasma Gematologiia i Transfuziologiia 31(4): 32-35
Hernández-Jerónimo, J.; Pérez-Campos, E.; Matadamas, C.ém.; Majluf-Cruz, A. 2003: A new thrombophilia risk factor: the increase of plasma factor VIIi Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 55(4): 448-457
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Bergen, J.R. 1970: Plasma factors, amines and their derivatives in schizophrenia Research Communications in Chemical Pathology and Pharmacology 1(3): 403-418
Zuch, A.; Rudobielska, M.; Zwierzowa, W.; Jurgielewicz, E.; Buluk, K. 1972: Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children Pediatria Polska 47(10): 1197-1203
Morozov, L.T. 1974: Toxicity of a dimethoxyphenylethylamine incubate with the blood plasma of schizophrenia patients Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 74(3): 396-398
Li, J.; Li, C.; Chai, L.; Gong, W. 2014: Relationship between plasma vascular endothelial growth factor and tumor necrosis factor-alpha and obstructive sleep apnea hypopnea syndrome in children Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(1): 44-48
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Perez-Polo, J.R.; Dy, P.; Westlund, K.; Hall, K.; Livingston, K. 1978: Levels of serum nerve growth factor in schizophrenia Birth Defects Original Article Series 14(5): 311-321
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Lane, H.Y.; Chiu, W.C.; Chou, J.C.; Wu, S.T.; Su, M.H.; Chang, W.H. 2000: Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels Journal of Clinical Psychiatry 61(3): 209-214
Egberg, N.; Gallimore, M.J. 1983: Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material Advances in Experimental Medicine and Biology 156: 1109-1117